| Literature DB >> 28166243 |
Qing Fan1, Zhixun Xie1, Zhiqin Xie1, Xianwen Deng1, Liji Xie1, Li Huang1, Sisi Luo1, Jiaoling Huang1, Yanfang Zhang1, Tingting Zeng1, Sheng Wang1, Jiabo Liu1, Yaoshan Pang1.
Abstract
Foot-and-mouth disease virus (FMDV), Bluetongue virus (BTV), Vesicular stomatitis Virus (VSV), Bovine viral diarrheal (BVDV), Bovine rotavirus (BRV), and Bovine herpesvirus 1 (IBRV) are common cattle infectious viruses that cause a great economic loss every year in many parts of the world. A rapid and high-throughput GenomeLab Gene Expression Profiler (GeXP) analyzer-based multiplex PCR assay was developed for the simultaneous detection and differentiation of these six cattle viruses. Six pairs of chimeric primers consisting of both the gene-specific primer and a universal primer were designed and used for amplification. Then capillary electrophoresis was used to separate the fluorescent labeled PCR products according to the amplicons size. The specificity of GeXP-multiplex PCR assay was examined with samples of the single template and mixed template of six viruses. The sensitivity was evaluated using the GeXP-multiplex PCR assay on serial 10-fold dilutions of ssRNAs obtained via in vitro transcription. To further evaluate the reliability, 305 clinical samples were tested by the GeXP-multiplex PCR assay. The results showed that the corresponding virus specific fragments of genes were amplified. The detection limit of the GeXP-multiplex PCR assay was 100 copies/μL in a mixed sample of ssRNAs containing target genes of six different cattle viruses, whereas the detection limit for the Gexp-mono PCR assay for a single target gene was 10 copies/μL. In detection of viruses in 305 clinical samples, the results of GeXP were consistent with simplex real-time PCR. Analysis of positive samples by sequencing demonstrated that the GeXP-multiplex PCR assay had no false positive samples of nonspecific amplification. In conclusion, this GeXP-multiplex PCR assay is a high throughput, specific, sensitive, rapid and simple method for the detection and differentiation of six cattle viruses. It is an effective tool that can be applied for the rapid differential diagnosis of clinical samples and for epidemiological investigation.Entities:
Year: 2017 PMID: 28166243 PMCID: PMC5293189 DOI: 10.1371/journal.pone.0171287
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Pathogens used and GeXP assay results.
| Pathogen | Source | GeXP Results | |||||
|---|---|---|---|---|---|---|---|
| FMDV | BTV | VSV | BVDV | BRV | IBRV | ||
| FMDV | |||||||
| FMDV serotype A inactivated virus | YNCIQ | + | - | - | - | - | - |
| FMDV serotype O inactivated virus | YNCIQ | + | - | - | - | - | - |
| FMDV serotype AsiaIinactivated virus | YNCIQ | + | - | - | - | - | - |
| FMDV serotype A inactivated vaccine | LVRI | + | - | - | - | - | - |
| FMDV serotype O inactivated vaccine | LVRI | + | - | - | - | - | - |
| FMDV serotype AsiaI inactivated vaccine | LVRI | + | - | - | - | - | - |
| BTV | |||||||
| BTV serotype 4 inactivated virus | YNCIQ | - | + | - | - | - | - |
| BTV serotype8 inactivated virus | YNCIQ | - | + | - | - | - | - |
| BTV serotype 9 inactivated virus | YNCIQ | - | + | - | - | - | - |
| BTV serotype 15 inactivated virus | YNCIQ | - | + | - | - | - | - |
| BTV serotype 17 inactivated virus | YNCIQ | - | + | - | - | - | - |
| BTV serotype 18 inactivated virus | YNCIQ | - | + | - | - | - | - |
| VSV | |||||||
| VSV serotype New Jersey inactivated virus | YNCIQ | - | - | + | - | - | - |
| VSV serotype Indiana inactivated virus | YNCIQ | - | - | + | - | - | - |
| BVDV | |||||||
| Oregon CV24 (BVDV-1) | CVCC | - | - | - | + | - | - |
| NADL (BVDV-1) | CVCC | - | - | - | + | - | - |
| AV68 (BVDV-1) | CVCC | - | - | - | + | - | - |
| GX-BVDV1 (BVDV-1) | GVRI | - | - | - | + | - | - |
| GX-BVDV2 (BVDV-1) | GVRI | - | - | - | + | - | - |
| GX-BVDV3 (BVDV-1) | GVRI | - | - | - | + | - | - |
| GX-BVDV4 (BVDV-1) | GVRI | - | - | - | + | - | - |
| GX-BVDV5 (BVDV-1) | GVRI | - | - | - | + | - | - |
| GX-BVDV6 (BVDV-1) | GVRI | - | - | - | + | - | - |
| GX-BVDV7 (BVDV-1) | GVRI | - | - | - | + | - | - |
| GX-BVDV8 (BVDV-1) | GVRI | - | - | - | + | - | - |
| GX-BVDV9 (BVDV-1) | GVRI | - | - | - | + | - | - |
| GX-BVDV10 (BVDV-1) | GVRI | - | - | - | + | - | - |
| GX-BVDV11 (BVDV-1) | GVRI | - | - | - | + | - | - |
| GX-BVDV12(BVDV-1) | GVRI | - | - | - | + | - | - |
| GX-BVDV13 (BVDV-1) | GVRI | - | - | - | + | - | - |
| GX-041 (BVDV-2) | GVRI | - | - | - | + | - | - |
| BRV | |||||||
| NCDV | CVCC | - | - | - | - | + | - |
| BRV014 | CVCC | - | - | - | - | + | - |
| GX-BRV1 | GVRI | - | - | - | - | + | - |
| GX-BRV2 | GVRI | - | - | - | - | + | - |
| GX-BRV3 | GVRI | - | - | - | - | + | - |
| GX-BRV4 | GVRI | - | - | - | - | + | - |
| GX-BRV5 | GVRI | - | - | - | - | + | - |
| GX-BRV6 | GVRI | - | - | - | - | + | - |
| GX-BRV7 | GVRI | - | - | - | - | + | - |
| GX-BRV8 | GVRI | - | - | - | - | + | - |
| IBRV | |||||||
| AV20/Barta Nu/67 | CVCC | - | - | - | - | - | + |
| AV21/BK125 | CVCC | - | - | - | - | - | + |
| Reference strain | |||||||
| PPRV inactivated virus | YNCIQ | - | - | - | - | - | - |
| ETEC | |||||||
| GX-ETEC1 | GVRI | - | - | - | - | - | - |
| GX-ETEC2 | GVRI | - | - | - | - | - | - |
| GX-ETEC3 | GVRI | - | - | - | - | - | - |
| Escherichia coli | |||||||
| C83919/1676 | CVCC | - | - | - | - | - | - |
| C83924/x114/83 | CVCC | - | - | - | - | - | - |
| C83922/b41 | CVCC | - | - | - | - | - | - |
| Mycoplasma bovis | |||||||
| GX/MB1 | GVRI | - | - | - | - | - | - |
| GX/MB2 | GVRI | - | - | - | - | - | - |
| Mycobacterium bovis | |||||||
| GXmt304 | GVRI | - | - | - | - | - | - |
| GXmt397 | GVRI | - | - | - | - | - | - |
| C680001 | CVCC | - | - | - | - | - | - |
| Salmonellosis/GXsal71 | GVRI | - | - | - | - | - | - |
GVRI = Guangxi Veterinary Research Institute;
YNCIQ = Yunnan Entry-Exit Inspection and Quarantine Bureau;
LVRI = Lanzhou Veterinary Research Institute;
CVCC = Chinese Veterinary Culture Collection Center.
Primer information.
| Primer | Forward primer sequence(5’-3’) | Reverse primer sequence(5’-3’) | Amplicon size (bp) | Target region | Primer concentration (μmol/L) |
|---|---|---|---|---|---|
| BTV | 136 | VP7 | 0.2 | ||
| FMDV | 166 | 3D | 0.2 | ||
| IBRV | 188 | gB | 0.2 | ||
| BRV | 211 | VP6 | 0.2 | ||
| VSV | 278 | N | 0.2 | ||
| BVDV | 308 | 5’-UTR | 2 |
Universal tag sequences were underlined. Chimeric primers were synthesized using universal primers and gene-specific primers.
Fig 1Specificity results of the GeXP-mono PCR assay.
A-F showed the results of the amplifications of BTV, FMDV, IBRV, BRV, VSV, and BVDV, respectively. The Y-axis indicates the dye signal, and X-axis indicate the PCR product size.
Fig 2Specificity results of the GeXP-multiplex PCR assay with mixed template of six cattle infectious viruses.
Fig 3Sensitivity results of GeXP-multiplex PCR assay.
GeXP-multiplex PCR assay was performed using serial 10-fold dilutions of premixed transcribed ssRNAs containing specific gene sequences of the 6 cattle viruses. A-D showed the results of equal amounts of template: 105, 104, 103, 102 copies per reactions in the GeXP-multiplex PCR assay. The viruses targets form left to right were as follow: BTV, FMDV, IBRV, BRV, VSV and BVDV.
Fig 4Interference results of GeXP-multiplex PCR assay.
GeXP-multiplex PCR was carried out with the following artificial mixture samples: sample A: FMDV (106 copies/μL) + IBRV (103 copies/μL) + BRV (103 copies/μL) + VSV (108 copies/μL), sample B: BTV (107 copies/μL) + IBRV (103 copies/μL) + BRV (103 copies/μL) + BVDV (105copies/μL).
Results of comparing the artificial mixed template with the single template by GeXP-multiplex PCR assay.
| Template | A.U. value of GeXP-multiplex PCR assay | |||||
|---|---|---|---|---|---|---|
| BTV | FMDV | IBRV | BRV | VSV | BVDV | |
| Sample A | 165.58 | 188.35 | 212.66 | 278.91 | ||
| FMDV (106 copies/μL) | 165.07 | |||||
| IBRV (103 copies/μL) | 188.24 | |||||
| BRV (103 copies/μL) | 212.15 | |||||
| VSV (108 copies/μL) | 278.59 | |||||
| Sample B | 135.88 | 188.19 | 212.56 | 309.42 | ||
| BTV (107 copies/μL) | 135.93 | |||||
| IBRV (103 copies/μL) | 188.75 | |||||
| BRV (103 copies/μL) | 212.21 | |||||
| BVDV (105 copies/μL) | 309.57 | |||||
Analysis of clinical samples using GeXP-multiplex PCR assay and simplex real-time PCR methods.
| Background of clinical samples | Clinical sample | Number | Positive results (GeXP-multiplex PCR / simplex real-time PCR /sequencing) | |||||
|---|---|---|---|---|---|---|---|---|
| BTV | FMDV | IBRV | BRV | VSV | BVDV | |||
| cattle without any morbid symptoms and signs | fecal swab | 141 | 3/3/3 | 18/18/18 | ||||
| blood sample | 70 | 32/32/32 | ||||||
| conjunctival swab | 30 | |||||||
| nasal mucus swab | 22 | |||||||
| Cattle showed typical symptoms of disease | oesophageal-pharyngeal fluid | 2 | 2/2/2 | |||||
| vesicular skins | 2 | 2/2/2 | ||||||
| vesicular fluid | 2 | 2/2/2 | ||||||
| mucous membrane | 10 | 10/10/10 | ||||||
| Fecal sample | 15 | 5/5/5/ | 10/10/10 | |||||
| lymph node | 3 | 3/3/3 | ||||||
| nasal mucus swab | 8 | 4/4/4 | ||||||
a Confirmed by OIE recommended real-time PCR detection of BTV, FMDV, IBRV, VSV, BVDV[24–28].
b Confirmed by simplex real-time PCR detection of BRV[29].